Interpretable machine-learning risk stratification at the time of diagnosis for 3-year mortality in de novo metastatic prostate cancer: development and temporal validation in SEER.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Temporal discrimination is moderate (AUC about 0.69–0.70); authors bound treatment conclusions as observational.
Technology: CatBoost and six other models for mortality risk prediction
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- CatBoost and six other models predict 3-year mortality using SEER data, then temporal and external cohorts.
- Limitation / still unknown
- Temporal validation and an independent external cohort are reported; claim is risk stratification, not treatment selection.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fonc.2026.1904589
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.